Come si colloca il rapporto 1345 di PE rispetto ai suoi colleghi?

1345 è costoso in base al suo rapporto Price-To-Earnings ( 14 x) rispetto alla media dei peer ( 12.1 x).

Come si colloca il 1345's PE Ratio rispetto ad altre aziende del HK Healthcare settore?

1345 è costoso in base al suo rapporto Price-To-Earnings ( 14 x) rispetto alla media del settore Hong Kong Healthcare ( 13 x).

Qual è il 1345 PE Ratio rispetto al suo Fair PE Ratio? Si tratta del PE Ratio atteso, tenendo conto delle previsioni di crescita degli utili, dei margini di profitto e di altri fattori di rischio della società.

Dati insufficienti per calcolare il Fair Ratio di 1345 Price-To-Earnings per l'analisi di valutazione.

Qual è il prezzo equo di 1345 se si considerano i suoi flussi di cassa futuri? Per questa stima utilizziamo un modello di Discounted Cash Flow.

1345 ( HK$2.12 ) viene scambiato al di sopra della nostra stima del [[fair value]] ( HK$0.4 )

Qual è la previsione a 12 mesi degli analisti e abbiamo una qualche fiducia statistica nell'obiettivo di prezzo del consenso?

Dati insufficienti per mostrare la previsione dei prezzi.

Shanghai Pioneer Holding (SEHK:1345) - Prezzo delle azioni, notizie e analisi

1345 Panoramica delle azioni

1345 analisi fondamentale
Punteggio fiocco di neve
Valutazione	0/6
Crescita futura	0/6
Prestazioni passate	2/6
Salute finanziaria	5/6
Dividendi	1/6

Analisi del rischio

Non sono stati rilevati rischi per 1345 dai nostri controlli di rischio.

Shanghai Pioneer Holding Ltd Concorrenti

IVD Medical Holding

SEHK:1931

HK$3.0b

Tycoon Group Holdings

SEHK:3390

HK$2.8b

Charmacy Pharmaceutical

SEHK:2289

HK$1.0b

Sinco Pharmaceuticals Holdings

SEHK:6833

HK$370.0m

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Shanghai Pioneer Holding
Prezzi storici delle azioni
Prezzo attuale dell'azione	HK$2.12
Massimo di 52 settimane	HK$2.26
Minimo di 52 settimane	HK$1.31
Beta	0.45
1Variazione di 1 mese	1.92%
Variazione a 3 mesi	3.92%
Variazione di 1 anno	6.00%
3Variazione a 3 anni	73.77%
Variazione a 5 anni	271.93%
Variazione dall'IPO	-44.79%

Notizie e aggiornamenti recenti

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15

Recent updates

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Jul 15

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Apr 24

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Apr 03

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Apr 01

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Mar 22

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Feb 26

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Oct 21

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Sep 18

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

Sep 01

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Aug 09

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Apr 14

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Mar 31

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Dec 15

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

Sep 21

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Sep 02

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Jun 22

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

Apr 14

China Pioneer Pharma Holdings (HKG:1345) Will Be Hoping To Turn Its Returns On Capital Around

Jan 16

These 4 Measures Indicate That China Pioneer Pharma Holdings (HKG:1345) Is Using Debt Safely

Oct 11

China Pioneer Pharma Holdings (HKG:1345) Is Paying Out Less In Dividends Than Last Year

Sep 15

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.056

Sep 01

China Pioneer Pharma Holdings (HKG:1345) Will Be Looking To Turn Around Its Returns

Aug 26

Returns On Capital At China Pioneer Pharma Holdings (HKG:1345) Paint A Concerning Picture

May 22

We Think China Pioneer Pharma Holdings (HKG:1345) Can Stay On Top Of Its Debt

Apr 25

Can Mixed Financials Have A Negative Impact on China Pioneer Pharma Holdings Limited's 's (HKG:1345) Current Price Momentum?

Mar 14

How Has China Pioneer Pharma Holdings (HKG:1345) Allocated Its Capital?

Feb 21

Should You Use China Pioneer Pharma Holdings' (HKG:1345) Statutory Earnings To Analyse It?

Feb 03

Is China Pioneer Pharma Holdings Limited (HKG:1345) At Risk Of Cutting Its Dividend?

Jan 16

China Pioneer Pharma Holdings (HKG:1345) Has A Rock Solid Balance Sheet

Dec 29

Is China Pioneer Pharma Holdings Limited's (HKG:1345) Stock Price Struggling As A Result Of Its Mixed Financials?

Dec 14

China Pioneer Pharma Holdings (HKG:1345) Has Gifted Shareholders With A Fantastic 124% Total Return On Their Investment

Nov 29

Rendimenti per gli azionisti

	1345	HK Healthcare	HK Mercato
7D	6.0%	-1.5%	-0.6%
1Y	6.0%	-27.6%	9.6%

Ritorno vs Industria: 1345 ha superato il Hong Kong Healthcare che ha restituito -27.6 % nell'ultimo anno.

Rendimento vs Mercato: 1345 ha avuto una performance inferiore al mercato Hong Kong che ha registrato un rendimento 9.6 % nell'ultimo anno.

Volatilità dei prezzi

Is 1345's price volatile compared to industry and market?
1345 volatility
1345 Average Weekly Movement	6.8%
Healthcare Industry Average Movement	8.0%
Market Average Movement	8.9%
10% most volatile stocks in HK Market	19.2%
10% least volatile stocks in HK Market	4.3%

Prezzo delle azioni stabile: 1345 non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 7% ) di 1345 è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1996	319	Steven Yang	www.pioneer-pharma.com

Shanghai Pioneer Holding Ltd, una holding di investimento, commercializza, promuove e vende prodotti farmaceutici e dispositivi medici principalmente nella Repubblica Popolare Cinese. L'azienda offre prodotti farmaceutici per l'oftalmologia, la gestione del dolore, il settore cardiovascolare, l'immunologia, la ginecologia, la gastroenterologia e altre aree terapeutiche. Vende anche dispositivi medici, tra cui prodotti per l'oftalmologia, l'ortopedia, l'odontologia e la cura delle ferite.

Shanghai Pioneer Holding Ltd Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Shanghai Pioneer Holding con la sua capitalizzazione di mercato?
1345 statistiche fondamentali
Capitalizzazione di mercato	HK$2.47b
Guadagni(TTM)	HK$175.80m
Ricavi(TTM)	HK$1.77b

14.0x

Rapporto P/E

1.4x

Rapporto P/S

1345 è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
1345 Conto economico (TTM)
Ricavi	CN¥1.65b
Costo del fatturato	CN¥945.43m
Profitto lordo	CN¥702.31m
Altre spese	CN¥538.63m
Guadagni	CN¥163.67m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)	0.14
Margine lordo	42.62%
Margine di profitto netto	9.93%
Rapporto debito/patrimonio netto	6.1%

Come si è comportato 1345 nel lungo periodo?

Vedi performance storica e confronto

Dividendi

2.2%

Rendimento attuale del dividendo

47%

Rapporto di remunerazione

1345 Panoramica delle azioni

Analisi del rischio

Shanghai Pioneer Holding Ltd Concorrenti

SEHK:1931

HK$3.0b

SEHK:3390

HK$2.8b

SEHK:2289

HK$1.0b

SEHK:6833

HK$370.0m

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Upcoming dividend of HK$0.048 per share

First half 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.065 in 1H 2023)

Shanghai Pioneer Holding Ltd Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2024, Payable on 15 November 2024

Shanghai Pioneer Holding Ltd to Report First Half, 2024 Results on Aug 28, 2024

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Upcoming dividend of HK$0.024 per share

Recent updates

Upcoming dividend of HK$0.048 per share

First half 2024 earnings released: EPS: CN¥0.081 (vs CN¥0.065 in 1H 2023)

Shanghai Pioneer Holding Ltd Announces Interim (Semi-Annual) Dividend for the Six Months Ended 30 June 2024, Payable on 15 November 2024

Shanghai Pioneer Holding Ltd to Report First Half, 2024 Results on Aug 28, 2024

Shareholders Should Be Pleased With Shanghai Pioneer Holding Ltd's (HKG:1345) Price

Upcoming dividend of HK$0.024 per share

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding's (HKG:1345) Dividend Will Be CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Will Pay A Dividend Of CN¥0.024

Shanghai Pioneer Holding's (HKG:1345) Shareholders Have More To Worry About Than Only Soft Earnings

Investor sentiment improves as stock rises 21%

Final dividend of HK$0.024 announced

Shanghai Pioneer Holding Ltd, Annual General Meeting, May 24, 2024

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥0.20 in FY 2022)

Shanghai Pioneer Holding Ltd (HKG:1345) Could Be Riskier Than It Looks

Shanghai Pioneer Holding Ltd to Report Fiscal Year 2023 Results on Mar 25, 2024

Shanghai Pioneer Holding (HKG:1345) Is Finding It Tricky To Allocate Its Capital

Now 23% overvalued

New minor risk - Share price stability

Does Shanghai Pioneer Holding (HKG:1345) Have A Healthy Balance Sheet?

Less than half of directors are independent

Shanghai Pioneer Holding Ltd Announces Board Changes

New major risk - Earnings quality

Upcoming dividend of HK$0.024 per share at 3.0% yield

Shanghai Pioneer Holding (HKG:1345) Has Announced That It Will Be Increasing Its Dividend To CN¥0.024

Shanghai Pioneer Holding (HKG:1345) Is Increasing Its Dividend To CN¥0.024

First half 2023 earnings released: EPS: CN¥0.065 (vs CN¥0.10 in 1H 2022)

Shanghai Pioneer Holding Ltd Announces Interim Dividend for the Six Months Ended June 30, 2023, Payable on October 20, 2023

Shanghai Pioneer Holding Ltd to Report First Half, 2023 Results on Aug 29, 2023

Here's Why We Think Shanghai Pioneer Holding (HKG:1345) Is Well Worth Watching

Investor sentiment deteriorates as stock falls 15%

Upcoming dividend of HK$0.048 per share at 2.4% yield

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Investor sentiment improves as stock rises 23%

Shanghai Pioneer Holding's (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

Full year 2022 earnings released

Shanghai Pioneer Holding Ltd Provides Earnings Guidance for the Year Ended 31 December 2022

Shanghai Pioneer Holding Ltd to Report Fiscal Year 2022 Results on Mar 27, 2023

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Shanghai Pioneer Holding (HKG:1345) Seems To Use Debt Rather Sparingly

Less than half of directors are independent

Upcoming dividend of HK$0.018 per share

China Pioneer Pharma Holdings' (HKG:1345) Dividend Will Be Reduced To CN¥0.018

China Pioneer Pharma Holdings Limited Announces Management Changes

Investor sentiment improved over the past week

China Pioneer Pharma Holdings' (HKG:1345) Shareholders Will Receive A Smaller Dividend Than Last Year

First half 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.057 in 1H 2021)

China Pioneer Pharma Holdings Limited Announces Interim Dividend for the Six Months Ended 30 June 2022, Payable on 20 October 2022

China Pioneer Pharma Holdings Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings (HKG:1345) Has More To Do To Multiply In Value Going Forward

Upcoming dividend of HK$0.064 per share

Less than half of directors are independent

China Pioneer Pharma Holdings (HKG:1345) Has Announced That Its Dividend Will Be Reduced To HK$0.064

China Pioneer Pharma Holdings Limited, Annual General Meeting, May 18, 2022

Full year 2021 earnings released: EPS: CN¥0.12 (vs CN¥0.043 in FY 2020)

China Pioneer Pharma Holdings Limited Announces Dividend for the Year Ended 31 December 2021, Payable on 10 June 2022

Investor sentiment improved over the past week

China Pioneer Pharma Holdings Limited to Report Fiscal Year 2021 Results on Mar 31, 2022